Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1H-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
go back to main search page
Accession:CHEBI:105352 term browser browse the term
Definition:A heterocyclic compound that has formula C7H6N8O2.
Synonyms:related_synonym: Formula=C7H6N8O2;   InChI=1S/C7H6N8O2/c1-2-3(13-16-12-2)6-9-7(11-10-6)4-5(8)15-17-14-4/h1H3,(H2,8,15)(H,9,10,11);   InChIKey=ZQZQNNAHUAEZSY-UHFFFAOYSA-N;   SMILES=CC1=NON=C1C2=NC(=NN2)C3=NON=C3N
 xref: LINCS:LSM-16715


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19770
    chemical entity 19769
      group 19679
        polyatomic entity 19678
          molecule 19489
            cyclic compound 19252
              heterocyclic compound 18293
                4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1H-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19770
    subatomic particle 19768
      composite particle 19768
        hadron 19768
          baryon 19768
            nucleon 19768
              atomic nucleus 19768
                atom 19768
                  main group element atom 19653
                    p-block element atom 19653
                      p-block molecular entity 19653
                        pnictogen molecular entity 18573
                          nitrogen molecular entity 18449
                            amide 17214
                              secondary amide 5320
                                imide 5319
                                  dicarboximide 5288
                                    4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1H-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.